At one stage I have been following the charts closely for Lynas, but then someone once told me before that "charts are made", i.e. they're a good guide, but they can be deceiving at times.
Jumping to the fundamentals, Lynas can just be right at the centre of the action as an outcome of trade spat between US and China. There is almost no way that rare earths don't get dragged into the dispute. In order for US to reduce reliance on China on a strategic perspective, USA actually wants a price rise in Rare Earths in order to stimulate the supply action to kick into full gear across the world. Imposing tariffs for supply from China is probably just a first step in encouraging development of supplies from ROW. Whilst we wait for the next few years to bring on alternative supplies, Lynas being the only ROW operating plant is the 1st runner (coz there's simply no one else!) to benefit from the price rise and have higher negotiating power to get longer term supply deals. Lynas over the next few years will do well.
- Forums
- ASX - By Stock
- LYC
- Today's chart & trading
Today's chart & trading, page-356
-
-
- There are more pages in this discussion • 1,913 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
|
|||||
Last
$6.35 |
Change
0.000(0.00%) |
Mkt cap ! $5.935B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 414 | $6.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.04 | 110 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 395 | 6.660 |
5 | 1989 | 6.550 |
1 | 174 | 6.530 |
1 | 71 | 6.480 |
1 | 545 | 6.470 |
Price($) | Vol. | No. |
---|---|---|
6.040 | 110 | 1 |
6.050 | 646 | 1 |
6.130 | 63 | 2 |
6.150 | 1000 | 1 |
6.190 | 2180 | 2 |
Last trade - 09.45am 16/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online